IVF Devices & Consumables Market by Product (Accessories & Disposables, Instruments, Reagents & Media), Technology Type (Donor Egg IVF, Fresh Embryo IVF, Frozen Embryo IVF), End User - Global Forecast 2024-2030
The IVF Devices & Consumables Market size was estimated at USD 2.85 billion in 2023 and expected to reach USD 3.35 billion in 2024, at a CAGR 17.64% to reach USD 8.91 billion by 2030.
In vitro fertilization (IVF) devices & consumables encompass a range of products and technologies used to assist in the process of artificial fertilization. This includes equipment and supplies utilized to perform procedures such as egg retrieval, sperm isolation, fertilization, and embryo culture, alongside storage systems for cryopreservation. IVF devices provide a controlled environment with optimal conditions for cell growth, which is crucial for developing embryos outside the human body. Consumables are used for various purposes, such as assessing the viability of sperm or the readiness of eggs for fertilization. The prevalence of infertility globally significantly boosts the need for IVF devices & consumables. In addition, enhanced funding and investments in R&D to create more efficient and less invasive IVF technologies significantly enhance market dynamics. However, strict regulatory approval and frequent product recalls present a significant challenge for manufacturers. Moreover, the continual development of genetic screening methods, such as preimplantation genetic testing (PGT), allows for higher success rates of IVF procedures by selecting embryos with the highest potential for healthy development. This technological progression attracts more individuals and couples considering IVF treatments, boosting market growth.
Regional Insights
In the Americas, particularly in the United States and Canada, the IVF devices & consumables market is highly advanced, driven by technological innovation, high healthcare expenditure, and a growing prevalence of infertility due to lifestyle factors. Consumer needs in the region are focused on high success rates and advanced treatments for infertility. American consumers prefer cost-effective treatments due to partial insurance coverage, leading to a high demand for efficient and budget-friendly IVF consumables. In European countries, especially those within the EU, IVF devices and consumables markets are mature, with high consumer awareness and acceptance. Advanced healthcare systems and high awareness play significant roles in driving the market. At the same time, in the Middle East, cultural acceptance and rising infertility rates are pushing the growth of the IVF devices & consumables market. However, heavy regulatory environments and religious considerations shape the market dynamics. Countries, including Israel, are significant in technology adoption and have supportive policies promoting research in IVF technologies. Moreover, APAC’s IVF devices and consumables market is expanding rapidly due to changing government policies on family planning, growing disposable incomes, and increasing infertility rates. Consumers are increasingly opting for IVF procedures with regional companies are investing heavily in R&D, making technologies more accessible and adapted to local needs.
Market Insights
Market Dynamics
The market dynamics represent an ever-changing landscape of the IVF Devices & Consumables Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
Market Drivers
Rising prevalence of infertility rates globally and the need for effective IVF procedures
Supportive government incentives and subsidies for fertility treatments worldwide
Market Restraints
Expensive and complex IVF procedures and Limited Insurance Coverage for IVF Treatments
Market Opportunities
Innovations in imaging technologies and embryo monitoring systems for IVF procedures
Rise of venture capital in IVF technology startups for enhanced research and development
Market Challenges
Product recalls and limited standardization in IVF devices
Market Segmentation Analysis
Product: Utilization of consumables & precision instruments in IVF procedures to protect fragile biological materials
Technology Type: Increasing need for frozen embryo IVF to align with personal health, timing, and financial considerations
End User: Extensive usage of IVF devices & consumables in cryobanks to ensure the long-term viability of reproductive materials
Market Disruption Analysis
Porter’s Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the IVF Devices & Consumables Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the IVF Devices & Consumables Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Vitrolife AB Enhances IVF Clinical Management through Strategic Acquisition of eFertility
Vitrolife AB has strategically expanded its portfolio in the IVF sector by acquiring eFertility, which is aimed at improving IVF clinic operations. With this acquisition, Vitrolife aims to construct a comprehensive end-to-end platform that incorporates all aspects of the IVF process, promising a leap towards more efficient and integrated clinic management globally.
Pioneering Partnership in IVF Technology: GenEmbryomics Joins Forces with Progenesis for Advanced Embryo Screening
GenEmbryomics has forged a strategic partnership with Progenesis to enhance IVF treatments through advanced genetic screening. The collaboration revolves around the integration of GenEmbryomics' innovative Panacea-GenomeScreen PGT-WGS test into Progenesis's services, offering comprehensive screening for over 2500 serious genetic disorders to IVF patients. This test, applicable to standard IVF and intracytoplasmic sperm injection (ICSI) embryos, aims to improve IVF success rates by ensuring higher testing accuracy, which may also lead to reduced costs for patients.
Advancements in IVF Storage Solutions: Introducing TMRW's CryoLink for Enhanced Digital Specimen Management
TMRW Life Sciences unveiled CryoLink, a versatile new workstation that integrates digital management into frozen specimen inventory systems in IVF laboratories. This launch signifies a strategic expansion of TMRW’s Digital Specimen Management system, previously accessible only through the company’s automated storage platforms. CryoLink offers a less resource-intensive option by allowing clinics to interface with existing storage systems or TMRW’s proprietary solutions, including the CryoRobot Select, an FDA-cleared automated storage system known for its robust safety features.
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the IVF Devices & Consumables Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the IVF Devices & Consumables Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Astec Co., Ltd., Becton, Dickinson and Company, Biopsybell S.R.L., DSS Imagetech Pvt. Ltd., Eppendorf SE, Esco Micro Pte. Ltd., Fujifilm Irvine Scientific, Inc., Genea Biomedx Pty Ltd., Gynotec B.V., Hamilton Thorne Inc. by Hamilton Thorne Ltd. Group, Hunter Scientific Limited, Kitazato Corporation, LABOTECT GmbH, LABOX, spol. s r.o., Manina Medtech S.L., Merck KGaA, Nidacon International AB, Overture Life, PHC Holdings Corporation, Rocket Medical PLC by Röko, Shivani Scientific Industries Pvt. Ltd., Smiths Group PLC, The Cooper Companies, Inc., Thermo Fisher Scientific Inc., and Vitrolife AB.
Market Segmentation & Coverage
This research report categorizes the IVF Devices & Consumables Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Accessories & Disposables
Instruments
Cabinets
Cryosystems
Imaging Systems
Incubators
Micromanipulator
Ovum Aspiration Pump
Sperm Separation Systems
Reagents & Media
Technology Type
Donor Egg IVF
Fresh Embryo IVF
Frozen Embryo IVF
End User
Cryobanks
Fertility Clinics
Hospitals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
Please Note: PDF & Excel + Online Access - 1 Year
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of infertility rates globally and the need for effective IVF procedures
5.1.1.2. Supportive government incentives and subsidies for fertility treatments worldwide
5.1.2. Restraints
5.1.2.1. Expensive and complex IVF procedures and Limited Insurance Coverage for IVF Treatments
5.1.3. Opportunities
5.1.3.1. Innovations in imaging technologies and embryo monitoring systems for IVF procedures
5.1.3.2. Rise of venture capital in IVF technology startups for enhanced research and development
5.1.4. Challenges
5.1.4.1. Product recalls and limited standardization in IVF devices
5.2. Market Segmentation Analysis
5.2.1. Product: Utilization of consumables & precision instruments in IVF procedures to protect fragile biological materials
5.2.2. Technology Type: Increasing need for frozen embryo IVF to align with personal health, timing, and financial considerations
5.2.3. End User: Extensive usage of IVF devices & consumables in cryobanks to ensure the long-term viability of reproductive materials
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. IVF Devices & Consumables Market, by Product
6.1. Introduction
6.2. Accessories & Disposables
6.3. Instruments
6.4. Reagents & Media
7. IVF Devices & Consumables Market, by Technology Type
7.1. Introduction
7.2. Donor Egg IVF
7.3. Fresh Embryo IVF
7.4. Frozen Embryo IVF
8. IVF Devices & Consumables Market, by End User
8.1. Introduction
8.2. Cryobanks
8.3. Fertility Clinics
8.4. Hospitals
9. Americas IVF Devices & Consumables Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific IVF Devices & Consumables Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa IVF Devices & Consumables Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Vitrolife AB Enhances IVF Clinical Management through Strategic Acquisition of eFertility
12.3.2. Pioneering Partnership in IVF Technology: GenEmbryomics Joins Forces with Progenesis for Advanced Embryo Screening
12.3.3. Advancements in IVF Storage Solutions: Introducing TMRW's CryoLink for Enhanced Digital Specimen Management
12.3.4. Pioneering AI Integration in IVF: Alife Health Partners with Boston IVF to Optimize Treatment Outcomes